About Terumo Neuro (Formerly MicroVention, Inc.) We are in business to create and deliver Game-changing Impact™—innovations that redefine what is possible in neuroendovascular treatment to ...

Terumo Neuro, a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced that the company is showcasing its comprehensive and streamlined portfolio of stroke ...

Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance1-9 and Innovation – The New SOFIA™ Flow 88 Offers Reliable Trackability, Proximal Stability and ...

Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance and Innovation – The New SOFIA™ 88 Catheter Offers Reliable Trackability, Proximal Stability and ...

ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th ...

ALISO VIEJO, Calif. & NEW ORLEANS--(BUSINESS WIRE)--In honor of World Stroke Day on October 29, 2024, Terumo Neuro has partnered with Tulane University School of Medicine and Dr. Kendrick Johnson ...

--Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced the commercial availability of the SOFIA™ 88 Neurovascular ...

As Terumo Neuro, the company is poised to continue its legacy of innovation with an enhanced focus on driving impactful growth and leveraging Terumo’s global resources and reputation.

"Terumo Neuro's SOFIA 88 Neurovascular Support Catheter is truly one of the best products in this category, especially when using a short 8F sheath," said Dr. Ameer Hassan, Head of Neuroscience ...

Terumo Neuro's SOFIA Catheter Line is Backed By 10 Years of Proven Clinical Performance1-9 and Innovation - The New SOFIA Flow 88 Offers Reliable Trackability, Proximal Stability and Vessel-Friendly.